Transmembrane protein polymorphisms and resistance to T-20 (Enfuvirtide, Fuzeon(®)) in HIV-1 infected therapy-naive seroconverters and AIDS patients under HAART-T-20 therapy.

导出 LinkOut

翻译打印收藏纠错

作者： Vladimir A,Morozov ^[1] ; Alexei V,Morozov ^[2] ; Dirk,Schürmann ^[3] ; Heiko,Jessen ^[4] ; Claudia,Kücherer ^[2]

作者单位： HIV Variabilitat und moleculare Epidemiologie/P11, Robert Koch-Institut, 20 Nordufer, 13353, Berlin, Germany. Morozov@umbi.umd.edu. ^[1] HIV Variabilitat und moleculare Epidemiologie/P11, Robert Koch-Institut, 20 Nordufer, 13353, Berlin, Germany. ^[2] Department of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany. ^[3] Medical Practice, Berlin, Germany. ^[4]

DOI 10.1007/s11262-007-0111-2

PMID 27517683

发布时间 2017-11-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览9

Virus genes

2007年35卷3期

877页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Transmembrane protein polymorphisms and resistance to T-20 (Enfuvirtide, Fuzeon(®)) in HIV-1 infected therapy-naive seroconverters and AIDS patients under HAART-T-20 therapy.

Virus genes

相似文献

Virus genes

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Transmembrane protein polymorphisms and resistance to T-20 (Enfuvirtide, Fuzeon(®)) in HIV-1 infected therapy-naive seroconverters and AIDS patients under HAART-T-20 therapy.

Virus genes

相似文献

Virus genes

相关期刊

检索历史清除